Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation

被引：0
|
作者：
Kumar, Aravid S. Ravi [1 ]
Hofman, Michael S. [1 ]
机构：
[1] Univ Melbourne, Peter MacCallum Ctr Melbourne, Prostate Canc Theranost & Imaging Ctr Excellence, Mol Imaging & Therapeut Nucl Med Canc Imaging, Melbourne, Vic, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷 / 01期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
SAFETY;
D O I：
10.2967/jnumed.123.266638
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [31] Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy
    Mohammad Abuqbeitah
    Mustafa Demir
    Lebriz Uslu-Beşli
    Nami Yeyin
    Kerim Sönmezoğlu
    Radiation and Environmental Biophysics, 2018, 57 : 55 - 61
  • [32] Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer
    Gafita, Andrei
    Rauscher, Isabel
    Retz, Margitta
    Knorr, Karina
    Heck, Matthias
    Wester, Hans-Juergen
    D'Alessandria, Calogero
    Weber, Wolfgang A.
    Eiber, Matthias
    Tauber, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 644 - 648
  • [33] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [34] Baseline PSMA PET/CT as a predictive biomarker for toxicity and patient-reported outcomes in mCRPC patients undergoing 177Lu-PSMA radioligand therapy
    Murthy, Vishnu
    Lokre, Ojaswita
    Perk, Timothy G.
    Chen, Lucia
    Thin, Pan
    Nguyen, Kathleen
    Lira, Stephanie
    Alano, Rejah M.
    Gafita, Andrei
    Czernin, Johannes
    Calais, Jeremie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects
    Fuoco, Valentina
    Argiroffi, Giovanni
    Mazzaglia, Stefania
    Lorenzoni, Alice
    Guadalupi, Valentina
    Franza, Andrea
    Scalorbi, Federica
    Aliberti, Gianluca
    Chiesa, Carlo
    Procopio, Giuseppe
    Seregni, Ettore
    Maccauro, Marco
    TUMORI JOURNAL, 2022, 108 (04): : 315 - 325
  • [36] Radioligand Therapy With 177Lu-PSMA for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Dwivedi, Sada Nand
    Bal, Chandrasekhar
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 275 - 285
  • [37] Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer
    Andrei Gafita
    Hui Wang
    Robert Tauber
    Calogero D’Alessandria
    Wolfgang A. Weber
    Matthias Eiber
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2212 - 2213
  • [38] Dosimetric evaluation of the lacrimal glands in patients undergoing therapy with 177Lu-PSMA
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Ngoc, C. Nguyen
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S103
  • [39] 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor
    Has Simsek, Duygu
    Civan, Caner
    Ekenel, Meltem
    Kuyumcu, Serkan
    Sanli, Yasemin
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 415 - 418
  • [40] Renal Function after Radioligand Treatment with 177Lu-PSMA-617
    Ngoc, Christina Nguyen
    Happel, Christian
    Davis, Karen
    Groener, Daniel
    Mader, Nicolai
    Mandel, Philipp
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345